Vasodilator actions of abnormal‐cannabidiol in rat isolated small mesenteric artery
- 1 April 2003
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 138 (7) , 1320-1332
- https://doi.org/10.1038/sj.bjp.0705160
Abstract
1. The nonpsychoactive cannabinoid abnormal-cannabidiol (trans-4-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol) (abn-cbd) produced concentration-dependent relaxation of methoxamine-precontracted rat small mesenteric artery. Endothelial removal reduced abn-cbd potency six-fold without affecting the maximum relaxation. 2. In endothelium-intact vessels, abn-cbd was less potent under 60 mM KCl-induced tone and inhibited by combination of L-N(G)-nitroarginine methyl ester (L-NAME) (nitric oxide synthase inhibitor; 300 micro M), apamin (small conductance Ca(2+)-activated K(+) channels inhibitor; 50 nM) and charybdotoxin (inhibitor of intermediate conductance Ca(2+)-activated K(+) channels and large conductance Ca(2+)-activated K(+) channels BK(Ca); 50 nM). L-NAME alone or in combination with either toxin alone had little effect. 3. In intact vessels, relaxations to abn-cbd were inhibited by SR 141716A (cannabinoid receptor antagonist; 1 or 3 micro M). Concomitant addition of L-NAME, apamin and charybdotoxin had no further effect. Other cannabinoid receptor antagonists either had little (SR 144528; 1 micro M and AM 251; 1 micro M) or no effect (AM 630; 10 micro M and AM 281; 1 micro M). Inhibition of gap junctions, G(i/o) protein coupling and protein kinase A also had no effect. 4. Endothelium-independent relaxation to abn-cbd was unaffected by L-NAME, apamin plus charybdotoxin or capsaicin (10 micro M). Abn-cbd inhibited CaCl(2)-induced contractions in vessels with depleted intracellular Ca(2+) stores and stimulated with methoxamine or KCl. This was insensitive to SR 141716A (3 micro M) but greatly reduced in vessels stimulated with ionomycin (Ca(2+) ionophore; 1 micro M). 5. We conclude that abn-cbd relaxes the rat small mesenteric artery by endothelium-dependent activation of K(+) channels via SR 141716A-sensitive pathways, which do not involve CB(1) and CB(2) receptors. It also causes endothelium-independent, SR 141716A-insensitive, relaxation by inhibiting Ca(2+) entry through voltage-gated Ca(2+) channels.Keywords
This publication has 59 references indexed in Scilit:
- Evidence of a novel site mediating anandamide‐induced negative inotropic and coronary vasodilatator responses in rat isolated heartsBritish Journal of Pharmacology, 2002
- Mechanisms of anandamide‐induced vasorelaxation in rat isolated coronary arteriesBritish Journal of Pharmacology, 2001
- Vanilloid receptors on capsaicin‐sensitive sensory nerves mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed and small mesenteric arteriesBritish Journal of Pharmacology, 2000
- Mesenteric Vasodilation Mediated by Endothelial Anandamide ReceptorsHypertension, 1999
- The actions of the cannabinoid receptor antagonist, SR 141716A, in the rat isolated mesenteric arteryBritish Journal of Pharmacology, 1998
- The actions of some cannabinoid receptor ligands in the rat isolated mesenteric arteryBritish Journal of Pharmacology, 1998
- Modulation of relaxation to levcromakalim by S-nitroso-N-acetylpenicillamine (SNAP) and 8-bromo cyclic GMP in the rat isolated mesenteric arteryBritish Journal of Pharmacology, 1998
- CANNABINOID RECEPTORS AND THEIR ENDOGENOUS AGONISTSAnnual Review of Pharmacology and Toxicology, 1998
- Cyclic Nucleotides Regulate the Activity ofL-type Calcium Channels in Smooth Muscle Cells from Rat Portal VeinJournal of Molecular and Cellular Cardiology, 1997
- A cannabinoid with cardiovascular activity but no overt behavioral effectsCellular and Molecular Life Sciences, 1977